| scholarly article | Q13442814 |
| P2093 | author name string | Paul S Bernstein | |
| Kelly Nelson | |||
| Aruna Gorusupudi | |||
| P2860 | cites work | Vitamin E supplementation and macular degeneration: randomised controlled trial | Q24531484 |
| A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8 | Q24544001 | ||
| A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9 | Q24546140 | ||
| Complement factor H polymorphism in age-related macular degeneration | Q24553334 | ||
| Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19 | Q24554181 | ||
| Identification of StARD3 as a lutein-binding protein in the macula of the primate retina | Q24628314 | ||
| A longitudinal follow-up study of saffron supplementation in early age-related macular degeneration: sustained benefits to central retinal function | Q24628705 | ||
| Association between dietary fat intake and age-related macular degeneration in the Carotenoids in Age-Related Eye Disease Study (CAREDS): an ancillary study of the Women's Health Initiative | Q24628833 | ||
| Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women's Antioxidant and Folic Acid Cardiovascular Study | Q24647967 | ||
| Age-related macular degeneration: Complement in action | Q26770250 | ||
| Lipofuscin-formation in retinal pigment epithelial cells is reduced by antioxidants | Q43664504 | ||
| Dietary fat and risk for advanced age-related macular degeneration | Q43694046 | ||
| Five-year incidence of age-related maculopathy lesions: the Blue Mountains Eye Study | Q43830961 | ||
| Age-related changes in the morphology, absorption and fluorescence of melanosomes and lipofuscin granules of the retinal pigment epithelium | Q43873957 | ||
| Transformations of selected carotenoids in plasma, liver, and ocular tissues of humans and in nonprimate animal models. | Q44198727 | ||
| Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study | Q44212321 | ||
| Early age-related maculopathy in the cardiovascular health study | Q44268950 | ||
| The relationship of ocular factors to the incidence and progression of age-related maculopathy | Q44412742 | ||
| Lutein and zeaxanthin status and risk of age-related macular degeneration. | Q44453108 | ||
| High concentrations of plasma n3 fatty acids are associated with decreased risk for late age-related macular degeneration | Q44535356 | ||
| Age-related macular degeneration. Macular changes, prevalence and sex ratio. An epidemiological study of 1000 aged individuals | Q44799844 | ||
| Treatment response to antioxidants and zinc based on CFH and ARMS2 genetic risk allele number in the Age-Related Eye Disease Study | Q44915960 | ||
| Identification and characterization of a Pi isoform of glutathione S-transferase (GSTP1) as a zeaxanthin-binding protein in the macula of the human eye. | Q45050501 | ||
| The singlet oxygen and carotenoid interaction | Q45187333 | ||
| Six-year supplementation with alpha-tocopherol and beta-carotene and age-related maculopathy | Q45248873 | ||
| Dietary fatty acids and the 10-year incidence of age-related macular degeneration: the Blue Mountains Eye Study. | Q46015886 | ||
| Nutritional AMD treatment phase I (NAT-1): feasibility of oral DHA supplementation in age-related macular degeneration | Q46175309 | ||
| Reduced zinc and copper in the retinal pigment epithelium and choroid in age-related macular degeneration | Q46321294 | ||
| Macular pigment and visual performance under glare conditions | Q46736128 | ||
| Further mapping of 10q26 supports strong association of HTRA1 polymorphisms with age-related macular degeneration. | Q46799572 | ||
| Effect of simultaneous, single oral doses of beta-carotene with lutein or lycopene on the beta-carotene and retinyl ester responses in the triacylglycerol-rich lipoprotein fraction of men. | Q47842512 | ||
| beta-Carotene: an unusual type of lipid antioxidant | Q47860141 | ||
| Oral docosahexaenoic acid in the prevention of exudative age-related macular degeneration: the Nutritional AMD Treatment 2 study. | Q50495466 | ||
| Risk factors for age-related macular degeneration: Pooled findings from three continents. | Q50506048 | ||
| The lipofuscin fluorophore A2E mediates blue light-induced damage to retinal pigmented epithelial cells. | Q50511473 | ||
| Dietary antioxidants and age-related maculopathy: the Blue Mountains Eye Study. | Q50519339 | ||
| Iris color, skin sun sensitivity, and age-related maculopathy. The Blue Mountains Eye Study. | Q50523104 | ||
| Senile macular degeneration: a case-control study. | Q50927753 | ||
| Dietary omega-3 fatty acids and the risk for age-related maculopathy: the Alienor Study. | Q51554097 | ||
| Are antioxidants or supplements protective for age-related macular degeneration? | Q51596706 | ||
| Five heavy metallic elements and age-related macular degeneration: Korean National Health and Nutrition Examination Survey, 2008-2011. | Q53260001 | ||
| Light exposure and the risk of age-related macular degeneration: the Pathologies Oculaires Liées à l'Age (POLA) study. | Q53321018 | ||
| Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration: the US Twin Study of Age-Related Macular Degeneration. | Q53529956 | ||
| Manganese superoxide dismutase gene (SOD2) polymorphism and exudative age-related macular degeneration in the Japanese population. | Q54527531 | ||
| Combined Optic Neuropathy and Myelopathy Secondary to Copper Deficiency | Q56552179 | ||
| Homocysteine, folate, vitamin B-12, and 10-y incidence of age-related macular degeneration | Q57103122 | ||
| The Grading and Prevalence of Macular Degeneration in Chesapeake Bay Watermen | Q57245152 | ||
| Acceleration of Age-Related Changes in the Retina in α-Tocopherol Transfer Protein Null Mice Fed a Vitamin E–Deficient Diet | Q57669476 | ||
| Dose-Ranging Study of Lutein Supplementation in Persons Aged 60 Years or Older | Q59325038 | ||
| Associations Between Intermediate Age-Related Macular Degeneration and Lutein and Zeaxanthin in the Carotenoids in Age-Related Eye Disease Study (CAREDS) | Q63344335 | ||
| Interaction of Fe3+, Cu2+ and Zn2+ with melanin and melanoproteins from bovine eyes | Q67941294 | ||
| Oral zinc in macular degeneration | Q68126625 | ||
| Prevalence of age-related maculopathy. The Beaver Dam Eye Study | Q68207448 | ||
| The regional distribution of vitamins E and C in mature and premature human retinas | Q68249436 | ||
| Analysis of the macular pigment by HPLC: retinal distribution and age study | Q68367274 | ||
| Choroidal neovascularization | Q68983919 | ||
| Polyunsaturated fatty acids and vitamin E in rat rod outer segments during light damage | Q69490668 | ||
| Sunlight and age-related macular degeneration. The Beaver Dam Eye Study | Q70655027 | ||
| Antioxidant status and neovascular age-related macular degeneration. Eye Disease Case-Control Study Group | Q72068439 | ||
| The prevalence of age-related maculopathy in the Rotterdam Study | Q72560755 | ||
| Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the Beaver Dam Eye Study | Q74805233 | ||
| Serum vitamin E levels negatively correlate with severity of age-related macular degeneration | Q77373882 | ||
| Effect of dietary lutein and zeaxanthin on plasma carotenoids and their transport in lipoproteins in age-related macular degeneration | Q79896842 | ||
| Age-related macular degeneration is the leading cause of blindness... | Q79989973 | ||
| Plasma lutein and zeaxanthin and other carotenoids as modifiable risk factors for age-related maculopathy and cataract: the POLA Study | Q83839560 | ||
| Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration | Q39575237 | ||
| Analysis of six genetic risk factors highly associated with AMD in the region surrounding ARMS2 and HTRA1 on chromosome 10, region q26. | Q39926724 | ||
| Prevalence of age-related macular degeneration in the US population | Q39966032 | ||
| The roles of vitamin E and unsaturated fatty acids in the visual process | Q40081578 | ||
| Accumulation and retention of micellar beta-carotene and lutein by Caco-2 human intestinal cells | Q40493188 | ||
| Oxy-radicals and cancer | Q40625911 | ||
| Whole blood selenium in exudative age-related maculopathy | Q40863368 | ||
| Structure and properties of carotenoids in relation to function | Q40928254 | ||
| Beta-carotene, carotenoids, and disease prevention in humans. | Q40989710 | ||
| Biological activities of natural and synthetic carotenoids: induction of gap junctional communication and singlet oxygen quenching. | Q41140948 | ||
| Retinal light damage reduces autofluorescent pigment deposition in the retinal pigment epithelium. | Q41349187 | ||
| Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study | Q41654781 | ||
| Distribution of copper and zinc in mammalian eyes. Occurrence of metals in melanin fractions from eye tissues | Q42106153 | ||
| Age-related maculopathy and sunlight exposure evaluated by objective measurement | Q42288688 | ||
| Softening of drusen and subretinal neovascularization | Q42448118 | ||
| Failure of vitamin E to protect the retina against damage resulting from bright cyclic light exposure | Q42505055 | ||
| Competitive inhibition of carotenoid transport and tissue concentrations by high dose supplements of lutein, zeaxanthin and beta-carotene | Q43191416 | ||
| Macular pigment in donor eyes with and without AMD: a case-control study. | Q43514008 | ||
| Racial differences in the prevalence of age-related macular degeneration: the Baltimore Eye Survey | Q43587787 | ||
| The Relationship of Dietary Carotenoid and Vitamin A, E, and C Intake With Age-Related Macular Degeneration in a Case-Control Study | Q28248143 | ||
| Lutein + Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration | Q28290149 | ||
| Prevalence of age-related macular degeneration in the United States | Q29614964 | ||
| The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers | Q29616096 | ||
| Lutein, zeaxanthin, and meso-zeaxanthin: The basic and clinical science underlying carotenoid-based nutritional interventions against ocular disease | Q30693939 | ||
| Drusen in age-related macular degeneration: pathogenesis, natural course, and laser photocoagulation-induced regression | Q30761426 | ||
| Prospective study of dietary fat and the risk of age-related macular degeneration | Q31827376 | ||
| Risk factors for age-related macular degeneration | Q31926371 | ||
| Identification and quantitation of carotenoids and their metabolites in the tissues of the human eye. | Q31951685 | ||
| Lutein and zeaxanthin in the diet and serum and their relation to age-related maculopathy in the third national health and nutrition examination survey | Q32066253 | ||
| Eicosapentaenoic acid is anti-inflammatory in preventing choroidal neovascularization in mice | Q33295301 | ||
| Prospective cohort study of antioxidant vitamin supplement use and the risk of age-related maculopathy | Q33539123 | ||
| Omega-3 long-chain polyunsaturated fatty acid intake inversely associated with 12-year progression to advanced age-related macular degeneration | Q33613360 | ||
| The relationship of dietary omega-3 long-chain polyunsaturated fatty acid intake with incident age-related macular degeneration: AREDS report no. 23 | Q33613367 | ||
| Essential fatty acids in health and chronic disease | Q33729708 | ||
| Oxidative damage and age-related macular degeneration | Q33774187 | ||
| Dietary factors that affect the bioavailability of carotenoids | Q33854110 | ||
| Acute and bilateral blindness due to optic neuropathy associated with copper deficiency | Q33946258 | ||
| Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). | Q33977885 | ||
| Association of macular pigment density with plasma ω-3 fatty acids: the PIMAVOSA study | Q34138412 | ||
| Drusen and disciform macular detachment and degeneration | Q34205929 | ||
| Senile macular degeneration: a histopathologic study | Q34209340 | ||
| Carotenoids in the retina and lens: possible acute and chronic effects on human visual performance | Q34255912 | ||
| Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group | Q34323879 | ||
| Stereochemistry of the human macular carotenoids. | Q34364881 | ||
| Genetic susceptibility, dietary antioxidants, and long-term incidence of age-related macular degeneration in two populations | Q34388840 | ||
| Fasting plasma zeaxanthin response to Fructus barbarum L. (wolfberry; Kei Tze) in a food-based human supplementation trial. | Q34393077 | ||
| Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial | Q34405938 | ||
| Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance | Q34405945 | ||
| Dietary intake of antioxidants and risk of age-related macular degeneration | Q34479951 | ||
| Bioaccessibility of carotenoids and vitamin E from their main dietary sources | Q34579944 | ||
| High dose zinc increases hospital admissions due to genitourinary complications | Q34601776 | ||
| Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study | Q34657635 | ||
| Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins | Q34719127 | ||
| Long term effects of lutein, zeaxanthin and omega-3-LCPUFAs supplementation on optical density of macular pigment in AMD patients: the LUTEGA study | Q34733171 | ||
| Genetic testing in persons with age-related macular degeneration and the use of the AREDS supplements: to test or not to test? | Q34778837 | ||
| Oily fish consumption, dietary docosahexaenoic acid and eicosapentaenoic acid intakes, and associations with neovascular age-related macular degeneration. | Q34805968 | ||
| Age-Related Macular Degeneration: Etiology, Pathogenesis, and Therapeutic Strategies | Q35126780 | ||
| Regression of choroidal neovascularization results in macular atrophy in anti-vascular endothelial growth factor-treated eyes. | Q35251134 | ||
| Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation | Q35761464 | ||
| The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina | Q35957608 | ||
| Treatment of exudative age-related macular degeneration: many factors to consider | Q36088574 | ||
| Challenges to understanding and measuring carotenoid bioavailability | Q36159330 | ||
| Macular pigment imaging in AREDS2 participants: an ancillary study of AREDS2 subjects enrolled at the Moran Eye Center | Q36239449 | ||
| Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3 | Q36257030 | ||
| The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1) | Q36360812 | ||
| The role of inflammation in the pathogenesis of age-related macular degeneration | Q36405906 | ||
| Joint Associations of Diet, Lifestyle, and Genes with Age-Related Macular Degeneration | Q36468066 | ||
| Age-Related Macular Degeneration and Blindness due to Neovascular Maculopathy | Q36592901 | ||
| Associations of human retinal very long-chain polyunsaturated fatty acids with dietary lipid biomarkers | Q36617497 | ||
| Prospective study of lutein/zeaxanthin intake and risk of age-related macular degeneration | Q36825090 | ||
| Retinal carotenoids can attenuate formation of A2E in the retinal pigment epithelium | Q37196292 | ||
| Role of antioxidant enzymes and small molecular weight antioxidants in the pathogenesis of age-related macular degeneration (AMD) | Q37298565 | ||
| Combined effects of complement factor H genotypes, fish consumption, and inflammatory markers on long-term risk for age-related macular degeneration in a cohort | Q37321510 | ||
| Neuroprotectin D1-mediated anti-inflammatory and survival signaling in stroke, retinal degenerations, and Alzheimer's disease | Q37328906 | ||
| Changes in iron-regulatory proteins in the aged rodent neural retina | Q37462408 | ||
| The role of complement Factor H in age-related macular degeneration: a review. | Q37729464 | ||
| Implications of altered iron homeostasis for age-related macular degeneration. | Q37825219 | ||
| Consequences of oxidative stress in age-related macular degeneration | Q38003229 | ||
| Iron, zinc, and copper in retinal physiology and disease | Q38155606 | ||
| Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe: 1990-2010. | Q38199083 | ||
| Causes of vision loss worldwide, 1990-2010: a systematic analysis | Q38238049 | ||
| Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. | Q38238059 | ||
| An update on the role of omega-3 fatty acids on inflammatory and degenerative diseases. | Q38370798 | ||
| Indications for Omega-3 Long Chain Polyunsaturated Fatty Acid in the Prevention and Treatment of Cardiovascular Disease | Q38456171 | ||
| Sunlight exposure, antioxidants, and age-related macular degeneration | Q39006183 | ||
| Blueberry anthocyanins: protection against ageing and light-induced damage in retinal pigment epithelial cells | Q39454765 | ||
| Increased Macular Pigment Optical Density and Visual Acuity following Consumption of a Buttermilk Drink Containing Lutein-Enriched Egg Yolks: A Randomized, Double-Blind, Placebo-Controlled Trial | Q39533399 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 40-53 | |
| P577 | publication date | 2017-01-17 | |
| P1433 | published in | Advances in Nutrition | Q20821073 |
| P1476 | title | The Age-Related Eye Disease 2 Study: Micronutrients in the Treatment of Macular Degeneration | |
| P478 | volume | 8 |
| Q64901264 | A Critical Appraisal of National and International Clinical Practice Guidelines Reporting Nutritional Recommendations for Age-Related Macular Degeneration: Are Recommendations Evidence-Based? |
| Q58554131 | Antioxidant and Oxidative Stress: A Mutual Interplay in Age-Related Diseases |
| Q52657692 | Carotenoid supplementation and retinoic acid in immunoglobulin A regulation of the gut microbiota dysbiosis. |
| Q91924792 | Carotenoids: How Effective Are They to Prevent Age-Related Diseases? |
| Q47782065 | Cobalamin-Associated Superoxide Scavenging in Neuronal Cells Is a Potential Mechanism for Vitamin B12-Deprivation Optic Neuropathy |
| Q64930030 | Effect of Long-Term Xanthophyll and Anthocyanin Supplementation on Lutein and Zeaxanthin Serum Concentrations and Macular Pigment Optical Density in Postmenopausal Women. |
| Q92203836 | Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO) in Eyes With Pigment Epithelial Detachments Due to Age-Related Macular Degeneration |
| Q91660747 | Microvascular contributions to age-related macular degeneration (AMD): from mechanisms of choriocapillaris aging to novel interventions |
| Q93102835 | Nutrients for Prevention of Macular Degeneration and Eye-Related Diseases |
| Q55241036 | Patterns of Fundus Autofluorescence Lifetimes In Eyes of Individuals With Nonexudative Age-Related Macular Degeneration. |
| Q55054391 | Qualitative assessment of online information about age-related macular degeneration available in Portuguese. |
| Q59446743 | What do we know about the macular pigment in AMD: the past, the present, and the future |
Search more.